The membrane proteases ADAMs and hepsin are differentially expressed in renal cell carcinoma. Are they potential tumor markers?

Journal of Urology

Volumn 172, Issue 6 I, 2004, Pages 2162-2166

  Roemer, Andreas ^b   Schwettmann, Lutz ^b   Jung, Monika ^b   Stephan, Carsten ^b   Roigas, Jan ^b   Kristiansen, Glen ^b   Loening, Stefan A ^b   Lichtinghagen, Ralf ^b   Jung, Klaus ^a  

^a CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

^b NONE

Author keywords

Carcinoma, renal cell; Gene expression; Hepsin; Kidney; Tumor markers, biological

Indexed keywords

DISINTEGRIN; HEPSIN; MESSENGER RNA; METALLOPROTEINASE; PORPHOBILINOGEN DEAMINASE; PROTEINASE; TUMOR MARKER; UNCLASSIFIED DRUG;

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; FEMALE; HUMAN; HUMAN TISSUE; KIDNEY CARCINOMA; MALE; NEPHRECTOMY; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROTEIN EXPRESSION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION;

EID: 8644289994     PISSN: 00225347     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.ju.0000144602.01322.49     Document Type: Article

References (20)

1. Lohi, J., Leivo, I., Oivula, J., Lehto, V. P. and Virtanen, I.: Extracellular matrix in renal cell carcinomas. Histol Histopathol, 13: 785, 1998
2. Primakoff, P. and Myles, D. G.: The ADAM gene family: surface proteins with adhesion and protease activity. Trends Genet, 16: 83, 2000
3. Blobel, C. P.: Functional and biochemical characterization of ADAMs and their predicted role in protein ectodomain shedding. Inflamm Res, 51: 83, 2002
4. Seals, D. F. and Courtneidge, S. A.: The ADAMs family of metalloproteases: multidomain proteins with multiple functions. Genes Dev, 17: 7, 2003
5. Tsuji, A., Torres-Rosado, A., Arai, T., Le Beau, M. M., Lemons, R. S., Chou, S. H. et al: Hepsin, a cell membrane-associated protease. Characterization, tissue distribution, and gene localization. J Biol Chem, 266: 16948, 1991
6. Wolfsberg, T. G., Primakoff, P., Myles, D. G. and White, J. M.: ADAM, a novel family of membrane proteins containing A Disintegrin and Metalloprotease domain: multipotential functions in cell-cell and cell- matrix interactions. J Cell Biol, 131: 275, 1995
7. Stamenkovic, I.: Extracellular matrix remodelling: the role of matrix metalloproteinases. J Pathol, 200: 448, 2003
8. Iba, K., Albrechtsen, R., Gilpin, B. J., Loechel, F. and Wewer, U. M.: Cysteine-rich domain of human ADAM 12 (meltrin alpha) supports tumor cell adhesion. Am J Pathol, 154: 1489, 1999
9. McCulloch, D. R., Harvey, M. and Herington, A. C.: The expression of the ADAMs proteases in prostate cancer cell lines and their regulation by dihydrotestosterone. Mol Cell Endocrinol, 167: 11, 2000
10. Wu, E., Croucher, P. I. and McKie, N.: Expression of members of the novel membrane linked metalloproteinase family ADAM in cells derived from a range of haematological malignancies. Biochem Biophys Res Commun, 235: 437, 1997
11. Stephan, C., Yousef, G. M., Scorilas, A., Jung, K., Jung, M., Kristiansen, G. et al: Hepsin is highly over expressed in and is a new candidate for a prognostic indicator in prostate cancer. J Urol, 171: 187, 2004
12. Tanimoto, H., Yan, Y., Clarke, J., Korourian, S., Shigemasa, K., Parmley, T. H. et al: Hepsin, a cell surface serine protease identified in hepatoma cells, is overexpressed in ovarian cancer. Cancer Res, 57: 2884, 1997
13. Zacharski, L. R., Ornstein, D. L., Memoli, V. A., Rousseau, S. M. and Kisiel, W.: Expression of the factor VII activating protease, hepsin, in situ in renal cell carcinoma. Thromb Haemost, 79: 876, 1998
14. Kallakury, B. V., Karikehalli, S., Haholu, A., Sheehan, C. E., Azumi, N. and Ross, J. S.: Increased expression of matrix metalloproteinases 2 and 9 and tissue inhibitors of metalloproteinases 1 and 2 correlate with poor prognostic variables in renal cell carcinoma. Clin Cancer Res, 7: 3113, 2001
15. Yokoyama, H., Wada, T., Kobayashi, K., Kuno, K., Kurihara, H., Shindo, T. et al: A disintegrin and metalloproteinase with thrombospondin motifs (ADAMTS)- 1 null mutant mice develop renal lesions mimicking obstructive nephropathy. Nephrol Dial Transplant, suppl., 17: 39, 2002
16. Mahimkar, R. M., Baricos, W. H., Visaya, O., Pollock, A. S. and Lovett, D. H.: Identification, cellular distribution and potential function of the metalloprotease-disintegrin MDC9 in the kidney. J Am Soc Nephrol, 11: 595, 2000
17. DeClerck, Y. A,: Interactions between tumour cells and stromal cells and proteolytic modification of the extracellular matrix by metalloproteinases in cancer. Eur J Cancer, 36: 1258, 2000
18. Egeblad, M. and Werb, Z.: New functions for the matrix metalloproteinases in cancer progression. Nat Rev Cancer, 2: 161, 2002
19. Dhanasekaran, S. M., Barrette, T. R., Ghosh, D., Shah, R., Varambally, S., Kurachi, K. et al: Delineation of prognostic biomarkers in prostate cancer. Nature, 412: 822, 2001
20. Vu, T. K., Liu, R. W., Haaksma, C. J., Tomasek, J. J. and Howard, E. W.: Identification and cloning of the membrane-associated serine protease, hepsin, from mouse preimplantation embryos. J Biol Chem, 272: 31315, 1997